Wyatt D. Geist - 14 Nov 2025 Form 4 Insider Report for Tenon Medical, Inc. (TNON)

Role: Chief Innovation Officer
Signature: /s/ Wyatt Geist
Issuer symbol: TNON
Transactions as of: 14 Nov 2025
Net transactions value: $0
Form type: 4
Filing time: 18 Nov 2025, 20:01:43 UTC
Previous filing: 11 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Geist Wyatt D.	Chief Innovation Officer	104 COOPER CT., LOS GATOS	/s/ Wyatt Geist	18 Nov 2025	0002080676

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TNON	Common stock	Purchase		+19,455	+14%		157,569	14 Nov 2025	Direct	F1
holding	TNON	Common stock						350,765	14 Nov 2025	By SiVantage, Inc.	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNON	Common Stock Purchase Warrant	Purchase		+19,455			19,455	14 Nov 2025	Common Stock	19,455	$1.16	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 19,455 shares of common stock of the Issuer and warrants to purchase up to 19,455 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.
F2	Reflects the reporting person's indirect interest in 710,300 shares owned by SiVantage, Inc., a corporation in which the reporting person has a 49.38% equity interest.

Content

On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 19,455 shares of common stock of the Issuer and warrants to purchase up to 19,455 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.

Reflects the reporting person's indirect interest in 710,300 shares owned by SiVantage, Inc., a corporation in which the reporting person has a 49.38% equity interest.